Cambridge, UK and Indianapolis, US – 7 December 2018: Acacia Pharma Group plc (“Acacia Pharma” or “the Company”), a pharmaceutical company developing and commercialising hospital products for US and international…Original Article
You may also like
Merus Receives FDA Extension of PDUFA for Zenocutuzumab
Ionis Announces FDA Acceptance of New Drug Application...
Dizal Submits New Drug Application to the U.S. FDA for...
Neurotech Provides Update on BLA for NT-501 as a...
Unicycive Therapeutics Announces U.S. FDA Acceptance...
Aldeyra Therapeutics Announces FDA Acceptance for...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.